Product Information

METOPROLOL TARTRATE 37.5 MG TB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0756 per EA under NDC 72888010101. Its NADAC has been published 143 times since Feb 21, 2024.

FDA first approved this application on Oct 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOPROLOL TARTRATE 37.5 MG TB

METOPROLOL TARTRATE
$0.0756per EA

Strength

37.5 mg/1

NDC

72888010101

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

METOPROLOL TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA200981

FDA Approved

10/28/2014

TE Code

AB

On Market Since

12/1/2018

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL TARTRATE 37.5 MG TB has been published 143 times since Feb 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0756 per EA
All-time high$0.0809 (Apr 10, 2024)
All-time low$0.0581 (May 22, 2024)
52-week high$0.0773
52-week low$0.0756
Median price$0.0759
Average price$0.0743
Largest weekly change-19.6% (May 22, 2024)
Weeks tracked143
Tracking sinceFeb 21, 2024

Price History

1W

0.0%

1M

-0.4%

3M

-1.4%

6M

-0.9%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

-0.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METOPROLOL TARTRATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOPROLOL TARTRATE 37.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 37.5 MG TB, manufactured by Advagen Pharma Ltd., is $0.0756 per EA (NDC 72888010101), effective Nov 11, 2026.

How has the price of METOPROLOL TARTRATE 37.5 MG TB changed over time?

Over the history we have for it, the NADAC for METOPROLOL TARTRATE 37.5 MG TB has held within roughly two percent of its current level. It has been tracked across 143 weekly CMS publications since Feb 21, 2024.

What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 37.5 MG TB?

Since Feb 21, 2024, the NADAC for METOPROLOL TARTRATE 37.5 MG TB has ranged from a low of $0.0581 (May 22, 2024) to a high of $0.0809 (Apr 10, 2024), with a median of $0.0759 per EA.

Are there cheaper alternatives to METOPROLOL TARTRATE 37.5 MG TB?

No other NADAC-published product currently shares the active ingredient and strength of METOPROLOL TARTRATE 37.5 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METOPROLOL TARTRATE 37.5 MG TB?

METOPROLOL TARTRATE 37.5 MG TB (NDC 72888010101) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.